Philadelphia, PA – December 7, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the renewal of its universal shelf registration statement on Form S-3 was declared...

Philadelphia, PA – December 5, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Oppenheimer 23nd Annual Healthcare Conference on...

Philadelphia, PA – November 8, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for the fiscal 2013 first quarter ended September 30, 2012. For the first...

Philadelphia, PA – November 5, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has made a donation to the American Red Cross to support Hurricane Sandy relief efforts.

Philadelphia, PA – November 2, 2012 – Lannett Company, Inc. (NYSE MKT: LCI), today announced that the company will release its fiscal 2013 first quarter financial results on Thursday,...

Philadelphia, PA – September 14, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its...

Philadelphia, PA – September 13, 2012 – Lannett Company, Inc. (NYSE MKT: LCI ) today announced that the company will present at the UBS Global Life Sciences Conference on Wednesday,...

Philadelphia, PA – September 6, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for the fiscal 2012 fourth quarter and full year ended June 30, 2012. For...

Philadelphia, PA – August 29, 2012 – Lannett Company, Inc. (NYSE MKT: LCI), today announced that the company will release its fiscal 2012 fourth-quarter and full-year financial results...

Philadelphia, PA – July 16, 2012 – Lannett Company, Inc. (NYSE MKT: LCI), a manufacturer of generic pharmaceuticals, today announced that Jeffrey Farber, vice chairman of the board,...

Philadelphia, PA – May 11, 2012 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Paul Taveira to its board of...

Philadelphia, PA – May 8, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 third quarter and nine months ended March 31, 2012. For the...

Philadelphia, PA – May 2, 2012 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2012...

Philadelphia, PA – March 6, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the 24th Annual Roth OC Growth Stock Conference on Monday,...

Philadelphia, PA – February 7, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 second quarter and six months ended December 31, 2011....

Philadelphia, PA – January 31, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its...

Philadelphia, PA – January 30, 2012 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2012...

Philadelphia, PA – January 4, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special...